Cargando…

How we treat NK/T-cell lymphomas

Natural killer (NK)/T-cell lymphomas are aggressive malignancies with a predilection for Asian and South American populations. Epstein–Barr virus (EBV) infection in lymphoma cells is universal. Predominantly extranodal, NK/T-cell lymphomas are divided clinically into nasal (involving the nose and up...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tse, Eric, Zhao, Wei-Li, Xiong, Jie, Kwong, Yok-Lam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164389/ https://www.ncbi.nlm.nih.gov/pubmed/35659326 http://dx.doi.org/10.1186/s13045-022-01293-5

Ejemplares similares

The diagnosis and management of NK/T-cell lymphomas
por: Tse, Eric, et al.
Publicado: (2017)

Chidamide in the treatment of peripheral T-cell lymphoma
por: Chan, Thomas S, et al.
Publicado: (2017)

Recent Advances in the Diagnosis and Treatment of Natural Killer Cell Malignancies
por: Tse, Eric, et al.
Publicado: (2022)

Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic target
por: Tse, Eric, et al.
Publicado: (2015)

Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy
por: Carbone, Antonino, et al.
Publicado: (2014)

Non-gastric marginal zone B cell lymphoma: clinicopathologic features and treatment results
por: Gill, Harinder, et al.
Publicado: (2011)

T-cell large granular lymphocyte leukemia: an Asian perspective
por: Kwong, Yok-Lam, et al.
Publicado: (2010)

How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
por: Lumish, Melissa, et al.
Publicado: (2021)

NK-/T-cell lymphomas
por: Wang, Hua, et al.
Publicado: (2021)

Characterization of the humoral immune response to the EBV proteome in extranodal NK/T-cell lymphoma
por: Liu, Zhiwei, et al.
Publicado: (2021)

Extranodal T- and NK-cell lymphomas
por: de Leval, Laurence, et al.
Publicado: (2022)

Intravascular NK/T-Cell Lymphoma: What We Know about This Diagnostically Challenging, Aggressive Disease
por: Zanelli, Magda, et al.
Publicado: (2022)

Extranodal NK/T cell lymphoma
por: Jeong, Seong Hyun
Publicado: (2020)

F-18 Fluorodeoxyglucose non-avid hepatosplenic T cell lymphoma: a diagnostic pitfall
por: Ho, Siu-Lun, et al.
Publicado: (2011)

Reactivation of Epstein-Barr Virus Hepatitis in T/Natural Killer (NK) Cells Mimicking Liver T/NK-Cell Lymphoma
por: Kwong, Sara, et al.
Publicado: (2020)

T-cell prolymphocytic leukaemia: spontaneous immunophenotypical switch from CD4 to CD8 expression
por: Tse, Eric, et al.
Publicado: (2010)

EBV and the Pathogenesis of NK/T Cell Lymphoma
por: Montes-Mojarro, Ivonne A., et al.
Publicado: (2021)

MiRNAs and lncRNAs in NK cell biology and NK/T-cell lymphoma
por: Gao, FengXia, et al.
Publicado: (2020)

Advances and challenges of immunotherapies in NK/T cell lymphomas
por: He, Ling, et al.
Publicado: (2023)

How we treat glioblastoma
por: Weller, Michael, et al.
Publicado: (2019)

How we treat primary central nervous system lymphoma
por: Calimeri, T., et al.
Publicado: (2021)

Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group
por: Yoon, Dok Hyun, et al.
Publicado: (2020)

Mediastinal cryptococcosis masquerading as therapy-refractory lymphoma
por: Wong, Matthew, et al.
Publicado: (2010)

Nasal NK/T-cell lymphoma: epidemiology and pathogenesis
por: Aozasa, Katsuyuki, et al.
Publicado: (2008)

Oral arsenic trioxide for treating acute promyelocytic leukaemia: Implications for its worldwide epidemiology and beyond
por: Kumana, Cyrus R., et al.
Publicado: (2022)

The Pathologic and Genetic Characteristics of Extranodal NK/T-Cell Lymphoma
por: Kim, Hyunsung, et al.
Publicado: (2022)

Molecular pathogenic pathways in extranodal NK/T cell lymphoma
por: de Mel, Sanjay, et al.
Publicado: (2019)

STAT3 Dysregulation in Mature T and NK Cell Lymphomas
por: Seffens, Angelina, et al.
Publicado: (2019)

Rational Targets of Therapy in Extranodal NK/T-Cell Lymphoma
por: Major, Ajay, et al.
Publicado: (2023)

How we treat esophageal squamous cell carcinoma
por: Puhr, H.C., et al.
Publicado: (2023)

DNA Methylation of Tumor Suppressive miRNAs in Non-Hodgkin’s Lymphomas
por: Yim, Rita Lok-Hay, et al.
Publicado: (2012)

How we treat locoregional melanoma
por: Troiani, T., et al.
Publicado: (2021)

Should we treat pyrexia? And how do we do it?
por: Doyle, James F., et al.
Publicado: (2016)

Improvement of myocardial perfusion reserve detected by cardiovascular magnetic resonance after direct endomyocardial implantation of autologous bone marrow cells in patients with severe coronary artery disease
por: Chan, Carmen Wing-Sze, et al.
Publicado: (2010)

New Approaches for Treatment of Advanced Extranodal NK/T-Cell Lymphoma
por: Yi, Wu, et al.
Publicado: (2022)

Methylation of miR-155-3p in mantle cell lymphoma and other non-Hodgkin's lymphomas
por: Yim, Rita Lh, et al.
Publicado: (2014)

An autopsy case of primary extranodal NK/T cell lymphoma (extranodal NK/T-cell lymphoma) of the bile duct
por: Ito, Hiroyuki, et al.
Publicado: (2019)

How we treat metastatic colorectal cancer
por: De Falco, Vincenzo, et al.
Publicado: (2020)

How we treat patients with leptomeningeal metastases
por: Le Rhun, Emilie, et al.
Publicado: (2019)

Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study
por: Bachy, Emmanuel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tulcepvckp09u703j3t5fpj8vv